Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2011-06-16 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
110616 - Acquisition of own shares_NL.pdf
Transaction in Own Shares Classification · 99% confidence The document is a formal announcement in Dutch, dated June 16, 2011, detailing the purchase of UCB shares on the Brussels stock exchange. The title explicitly mentions "Aankoop van eigen aandelen" (Purchase of own shares) and the body provides a table listing the dates, prices, and quantities of shares bought back. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category.
2011-06-16 Dutch
110609 shares acquisition_ENG.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Acquisition of own shares in the framework of employees' long-term incentive plans" and explicitly states that UCB has acquired a specific number of its own shares on the Brussels stock exchange, detailing the dates and prices. This activity directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS). The document length is short (2292 chars), but it is a direct report of the transaction, not an announcement of a report's publication.
2011-06-09 English
110609 shares acquisition_FR.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Acquisition d'actions propres dans le cadre de rémunérations variables à long terme du personnel" (Acquisition of own shares under long-term variable remuneration for personnel). It explicitly states that UCB acquired 22,600 UCB shares on the Brussels stock exchange and details the dates and prices. This action directly corresponds to the company buying back or issuing its own shares, often related to employee compensation plans. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is short and appears to be a regulatory disclosure of this specific transaction, not a general announcement of a report (RPA) or a broad regulatory filing (RNS).
2011-06-09 French
110609 shares acquisition_NL.pdf
Share Issue/Capital Change Classification · 99% confidence The document is a formal announcement in Dutch regarding the 'Aankoop van eigen aandelen' (Purchase of own shares) executed on specific dates and prices, explicitly stating these shares were delivered to personnel exercising stock options. This activity directly relates to the company managing its own share capital, specifically through repurchases or transactions involving treasury stock for employee incentive plans. This aligns precisely with the definition for 'Transaction in Own Shares' (Code: POS). The document is short and structured like a regulatory disclosure, not a full report.
2011-06-09 Dutch
110601 shares acquisition_ENG.pdf
Transaction in Own Shares Classification · 99% confidence The document explicitly details the acquisition of UCB shares by the company itself, referencing 'Acquisition of own shares in the framework of employees' long-term incentive plans' and providing a table of transaction dates, prices, and amounts. This activity directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). This matches Filing Type Code POS (Transaction in Own Shares). The document is short and appears to be a regulatory disclosure of this specific transaction, not a general announcement of a report (RPA) or a broad regulatory filing (RNS).
2011-06-01 English
110601 shares acquisition_FR.pdf
Remuneration Information Classification · 99% confidence The document is titled "Acquisition d'actions propres dans le cadre de rémunérations variables à long terme du personnel" (Acquisition of own shares under long-term variable remuneration for personnel). It explicitly states that UCB acquired 12,250 UCB shares on the Brussels stock exchange and immediately delivered them to employees exercising stock options. This action—the company buying back or acquiring its own shares, often for employee compensation plans—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS. The document is short and is a direct announcement of the transaction, not a general regulatory filing (RNS) or a report publication announcement (RPA).
2011-06-01 French

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.